Metri Bio
About Metri Bio
Metri Bio is pioneering first-in-class therapeutics for endometrial disease, aiming to radically improve the lives of people suffering from diseases that impact the endometrium.
Over two billion women globally suffer from uterine diseases that affect the endometrium and surrounding tissues without effective disease-modifying targeted therapeutics. Metri Bio is addressing this critical gap.
The company highlights that diseases like endometriosis have debilitating systemic effects influencing immune, cardiovascular, and metabolic pathways, yet lack reliable disease targets and treatments due to limited modeling systems. Metri Bio's platform is designed to change this landscape.
Mission and Goals
The mission of Metri Bio is to radically improve the lives of patients with diseases of the endometrium by developing advanced therapeutic solutions.
Metri Bio is committed to pioneering novel therapies to modify disease pathways and provide targeted treatments for uterine diseases.